Definitive Contract 75N93019C00025
Award Date 8/14/19
Potential Completion Date 8/18/20
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Monrovia, CA 91016, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Chromologic LLC, a minority-owned small business, has been awarded a definitive fixed-price contract valued at $1,498,121 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of mobile health point-of-care diagnostics for malaria, to be performed in Monrovia, California, with work expected to be completed by January 2025. No set-aside designation was used for this award. Through...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract in the amount of $299,974 to Crosslife Technologies Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I project titled "A Rapid Nucleic Acid Test for the Point of Care Detection of Malaria." The contract was set aside for total small...
- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $299,937 firm fixed-price contract to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Phase I Small Business Innovation Research (SBIR) project titled "CHROMOLOGIC." The contract supports research and development efforts for a "CRIPR-BASED ASSAY FOR PORTABLE TROPICAL INFECTION DIAGNOSIS (CAPTIN-D)." There is no set-aside designation for this contract. Chromologic has...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services. The contract, valued at $225,000.00, was awarded to Hemex Health Inc., a for-profit medical diagnostics company that develops affordable point-of-care tests for diseases like sickle cell and malaria. The contract is focused on developing diagnostic...
- This is a Phase II Small Business Innovation Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chromologic LLC, a minority-owned small business headquartered in Monrovia, California. The award, valued at $1,499,763.00, is for the development of a CRISPR-based assay for portable tropical infection diagnosis (CAPTIN-D). This is a Firm Fixed Price definitive contract with a completion date of September 14, 2028. The award is...
- This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $224,997.00, was awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, to conduct research and development for the BICER program. The contract has a Firm Fixed Price pricing type and a completion date of September 9, 2016....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $300,000 Small Business Innovation Research (SBIR) Phase I contract to L2 Diagnostics LLC, a for-profit limited liability company based in Woodbridge, Connecticut. The contract, a Firm Fixed Price Definitive Contract with a performance period ending on November 30, 2025, is focused on discovering and validating novel diagnostic biomarkers for malaria. The contract is set aside for total small business participation. L2...
- This is a $299,633 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc., a Boston-based research and development firm. The contract is for the development of a "smartphone-integrated point-of-care sensor for rapid and sensitive detection of malaria in low-resource applications." Giner Inc. has experience delivering technology...